Jane Street
GH icon

Jane Street’s Guardant Health GH Stock Holding History

Jane Street’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.89M Sell
63,800
-69,200
-52% -$6.95M ﹤0.01% 3268
2025
Q4 		$13.6M Sell
133,000
-60,400
-31% -$5.4M ﹤0.01% 1963
2025
Q3 		$12.1M Buy
193,400
+105,000
+119% +$5.71M ﹤0.01% 2181
2025
Q2 		$4.6M Sell
88,400
-4,800
-5% -$214K ﹤0.01% 3115
2025
Q1 		$3.97M Buy
93,200
+54,400
+140% +$2.35M ﹤0.01% 3277
2024
Q4 		$1.19M Buy
38,800
+11,800
+44% +$332K ﹤0.01% 5052
2024
Q3 		$619K Sell
27,000
-14,900
-36% -$422K ﹤0.01% 6819
2024
Q2 		$1.21M Sell
41,900
-19,700
-32% -$459K ﹤0.01% 5418
2024
Q1 		$1.27M Sell
61,600
-17,200
-22% -$369K ﹤0.01% 4966
2023
Q4 		$2.13M Buy
78,800
+42,000
+114% +$1.1M ﹤0.01% 4206
2023
Q3 		$1.09M Sell
36,800
-600
-2% -$21.1K ﹤0.01% 5049
2023
Q2 		$1.34M Sell
37,400
-69,500
-65% -$2M ﹤0.01% 4759
2023
Q1 		$2.51M Sell
106,900
-67,700
-39% -$1.93M ﹤0.01% 3443
2022
Q4 		$4.75M Buy
174,600
+36,100
+26% +$1.65M ﹤0.01% 2560
2022
Q3 		$7.46M Buy
138,500
+19,300
+16% +$991K ﹤0.01% 2039
2022
Q2 		$4.81M Buy
119,200
+5,500
+5% +$273K ﹤0.01% 2710
2022
Q1 		$7.53M Buy
113,700
+15,700
+16% +$1.07M ﹤0.01% 2384
2021
Q4 		$9.8M Buy
98,000
+25,500
+35% +$2.64M ﹤0.01% 1911
2021
Q3 		$9.06M Sell
72,500
-100,800
-58% -$12M ﹤0.01% 1926
2021
Q2 		$21.5M Buy
173,300
+125,900
+266% +$16.9M 0.01% 1028
2021
Q1 		$7.24M Buy
47,400
+31,000
+189% +$4.69M ﹤0.01% 1914
2020
Q4 		$2.11M Sell
16,400
-56,300
-77% -$6.48M ﹤0.01% 3391
2020
Q3 		$8.13M Sell
72,700
-16,100
-18% -$1.47M ﹤0.01% 1384
2020
Q2 		$7.2M Buy
88,800
+77,500
+686% +$6.24M 0.01% 1450
2020
Q1 		$786K Sell
11,300
-7,400
-40% -$568K ﹤0.01% 3077
2019
Q4 		$1.46M Buy
18,700
+3,400
+22% +$245K ﹤0.01% 2298
2019
Q3 		$977K Buy
+15,300
New +$1.35M ﹤0.01% 2653

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's GH Position: Q1 2026 in Review

Jane Street reduced its Guardant Health (GH) stake by 99% in Q1 2026, selling an estimated $51.1M and leaving 4,803 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #8344.

Jane Street first reported a position in GH in Q2 2019 and has held it in 27 quarters since. The position peaked at $52.5M in Q4 2025. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Jane Street held 4,803 shares of Guardant Health worth $444K as of Q1 2026.
  • Jane Street sold 508,817 Guardant Health shares in Q1 2026, an estimated $51.1M.
  • Guardant Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8344 holding.
  • Jane Street first reported a position in Guardant Health in Q2 2019 and has held it in 27 quarters since.
  • Jane Street's Guardant Health position peaked at $52.5M in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.